Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
Stevanato Group S.p.A. Ordinary Shares (STVN)
Company Research
Source: Business Wire
- Establishes Fiscal 2026 Guidance - PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the fourth quarter and full year 2025.Fourth Quarter and Full Year 2025 Highlights (comparisons to prior-year periods)For the fourth quarter of 2025, revenue increased 5% (7% on a constant currency basis) to €346.5 million, and high-value solutions represented 49% of total revenue.Gross profit margin increased 120 basis points to 30.9%, and adjusted EBITDA margin increased 70 basis points to 28.2%, for the fourth quarter of 2025.Diluted earnings per share were €0.17, and adjusted diluted earnings per share were €0.18 for the fourth quarter of 2025.For the fiscal year 2025, revenue increased 7% (9% on a constant currency basis) to €1.186 billion, and high-value solutions represe
Show less
Read more
Impact Snapshot
Event Time:
STVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STVN alerts
High impacting Stevanato Group S.p.A. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
STVN
News
- Stevanato Group's (STVN) Core Business Improved Despite a 22% Pull Back in Q4 [Yahoo! Finance]Yahoo! Finance
- Stevanato Group (STVN) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c-)" to "sell (d+)".MarketBeat
- Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum [Yahoo! Finance]Yahoo! Finance
- Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare ForumBusiness Wire
- Stevanato Group (STVN) had its price target lowered by Morgan Stanley from $24.00 to $19.00. They now have an "equal weight" rating on the stock.MarketBeat
STVN
Earnings
- 3/4/26 - Miss
STVN
Sec Filings
- 3/25/26 - Form 3
- 3/25/26 - Form 3
- 3/18/26 - Form 3
- STVN's page on the SEC website